UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Macrophage colony stimulating factor: Not just for macrophages anymore! A gateway into complex biologies

International immunopharmacology, 2008-10, Vol.8 (10), p.1354-1376

2008

Volltextzugriff (PDF)

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a “paraptosis”-induced pathway that promotes systemic immunity against intracranial T9 gliomas

Blood, 2002-08, Vol.100 (4), p.1373-1380

2002

Volltextzugriff (PDF)

Antiangiogenic Drugs Synergize with a Membrane Macrophage Colony-Stimulating Factor-Based Tumor Vaccine to Therapeutically Treat Rats with an Established Malignant Intracranial Glioma

The Journal of immunology (1950), 2005-03, Vol.174 (5), p.2533-2543

2005

Volltextzugriff (PDF)

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light

Journal of the American Academy of Dermatology, 2001-07, Vol.45 (1), p.96-104

2001

Volltextzugriff (PDF)

Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles

Dermatology online journal, 2007-05, Vol.13 (2), p.4-4

2007

Volltextzugriff (PDF)

Intra-arterial administration of TNF-α followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

Cancer Immunology, Immunotherapy, 2003-01, Vol.52 (1), p.10-16

2003

Volltextzugriff (PDF)

Confluent and reticulate papillomatosis

Dermatology online journal, 2008-03, Vol.14 (3), p.10

2008

Volltextzugriff (PDF)

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials

Archives of dermatology (1960), 2004-01, Vol.140 (1), p.41

2004

Volltextzugriff (PDF)

Actinic keratosis. Current treatment options

American journal of clinical dermatology, 2000-05, Vol.1 (3), p.167-179

2000

Volltextzugriff (PDF)

Non-immunogenic Murine Hepatocellular Carcinoma Hepa1-6 Cells Expressing the Membrane Form of Macrophage Colony Stimulating Factor Are Rejected in Vivo and Lead to CD8+ T-Cell Immunity Against the Parental Tumor

Molecular therapy, 2001-11, Vol.4 (5), p.427-437

2001

Volltextzugriff (PDF)

Membrane Macrophage Colony-Stimulating Factor on MADB106 Breast Cancer Cells Does Not Activate Cytotoxic Macrophages but Immunizes Rats against Breast Cancer

Molecular therapy, 2001-02, Vol.3 (2), p.216-224

2001

Volltextzugriff (PDF)

Purification and Characterization of an Inhibitor (Soluble Tumor Necrosis Factor Receptor) for Tumor Necrosis Factor and Lymphotoxin Obtained from the Serum Ultrafiltrates of Human Cancer Patients

Proceedings of the National Academy of Sciences - PNAS, 1990-11, Vol.87 (22), p.8781-8784

1990

Volltextzugriff (PDF)

T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas

Cellular immunology, 2002, Vol.215 (1), p.1-11

2002

Volltextzugriff (PDF)

585. Anti-Angiogenic Drugs Synergize with a Membrane Macrophage Colony Stimulating Factor (mM-CSF) Based Tumor Vaccine to Therapeutically Treat Rats with an Established Intracranial Glioma

Molecular therapy, 2004-05, Vol.9 (S1), p.S221-S221

2004

Volltextzugriff (PDF)

Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor

International immunopharmacology, 2001-04, Vol.1 (4), p.737-748

2001

Volltextzugriff (PDF)

New Approaches to the Treatment of Actinic Keratosis

American journal of cancer (Auckland, N.Z.), 2003, Vol.2 (3), p.151-168

2003

Volltextzugriff (PDF)

Intra-arterial administration of TNF-a followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

Cancer immunology, immunotherapy, 2003-01, Vol.52 (1), p.10

2003

Volltextzugriff (PDF)

Photodynamic Therapy With Aminolevulinic Acid Topical Solution andVisible Blue Light in the Treatment of Multiple Actinic Keratoses of the Faceand Scalp: Investigator-Blinded, Phase 3, Multicenter Trials

Archives of dermatology (1960), 2004-01, Vol.140 (1)

2004

Volltextzugriff (PDF)

Relationship of Cloning Inhibition Factor, “Lymphotoxin” Factor, and Proliferation Inhibition Factor Release in Vitro by Mitogen-Activated Human Lymphocytes

The Journal of immunology (1950), 1975-01, Vol.114 (1_Part_1), p.64-69

1975

Volltextzugriff (PDF)

Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes. I: Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA

Journal of neuro-oncology, 1993-02, Vol.15 (2), p.141-155

1993

Volltextzugriff (PDF)

Congenital circumareolar telangiectasias: a uniquely distributed vascular malformation

Archives of dermatology (1960), 1990-12, Vol.126 (12), p.1656

1990

Volltextzugriff (PDF)

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study

Archives of dermatology (1960), 1997-06, Vol.133 (6), p.727

1997

Volltextzugriff (PDF)

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study

Archives of dermatology (1960), 1997-06, Vol.133 (6), p.727-732

Jeffes, E. W.

1997

Volltextzugriff (PDF)

Recombinant Human Cytokines Stimulate Neutrophil Adherence to IgG Autoantibody-Treated Epithelial Basement Membranes

Journal of investigative dermatology, 1990-08, Vol.95 (2), p.164-171

1990

Volltextzugriff (PDF)

Acantholysis producedin vitro with pemphigus serum: Hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysis

Journal of clinical immunology, 1984-09, Vol.4 (5), p.359-363

1984

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Macrophage colony stimulating factor: Not just for macrophages anymore! A gateway into complex biologies

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a “paraptosis”-induced pathway that promotes systemic immunity against intracranial T9 gliomas

Antiangiogenic Drugs Synergize with a Membrane Macrophage Colony-Stimulating Factor-Based Tumor Vaccine to Therapeutically Treat Rats with an Established Malignant Intracranial Glioma

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light

Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles

Intra-arterial administration of TNF-α followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

Confluent and reticulate papillomatosis

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials

Actinic keratosis. Current treatment options

Non-immunogenic Murine Hepatocellular Carcinoma Hepa1-6 Cells Expressing the Membrane Form of Macrophage Colony Stimulating Factor Are Rejected in Vivo and Lead to CD8+ T-Cell Immunity Against the Parental Tumor

Membrane Macrophage Colony-Stimulating Factor on MADB106 Breast Cancer Cells Does Not Activate Cytotoxic Macrophages but Immunizes Rats against Breast Cancer

Purification and Characterization of an Inhibitor (Soluble Tumor Necrosis Factor Receptor) for Tumor Necrosis Factor and Lymphotoxin Obtained from the Serum Ultrafiltrates of Human Cancer Patients

T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas

585. Anti-Angiogenic Drugs Synergize with a Membrane Macrophage Colony Stimulating Factor (mM-CSF) Based Tumor Vaccine to Therapeutically Treat Rats with an Established Intracranial Glioma

Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor

New Approaches to the Treatment of Actinic Keratosis

Intra-arterial administration of TNF-a followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

Photodynamic Therapy With Aminolevulinic Acid Topical Solution andVisible Blue Light in the Treatment of Multiple Actinic Keratoses of the Faceand Scalp: Investigator-Blinded, Phase 3, Multicenter Trials

Relationship of Cloning Inhibition Factor, “Lymphotoxin” Factor, and Proliferation Inhibition Factor Release in Vitro by Mitogen-Activated Human Lymphocytes

Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes. I: Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA

Congenital circumareolar telangiectasias: a uniquely distributed vascular malformation

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study

Recombinant Human Cytokines Stimulate Neutrophil Adherence to IgG Autoantibody-Treated Epithelial Basement Membranes

Acantholysis producedin vitro with pemphigus serum: Hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysis

Suchergebnisse filtern